Concepedia

A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer

Melissa A. Geller, Sarah Cooley, Patricia L. Judson, Rahel Ghebre, Linda F. Carson, Peter A. Argenta, Amy L. Jonson, Angela Panoskaltsis‐Mortari, Julie Curtsinger, David H. McKenna,

Cytotherapy · 2010 · 430 citations · 43 references

DOI

Concepts

References

43

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +12

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

Tyler J. Curiel, George Coukos, Linhua Zou et al. · Nature Medicine · 2004 · 5.1K citations

, , +16

A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone

Steven A. Rosenberg, Michael T. Lotze, Linda Muul et al. · New England Journal of Medicine · 1987 · 2.8K citations

, , +14

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

Jeffrey S. Miller, Yvette Soignier, Angela Panoskaltsis‐Mortari et al. · Blood · 2005 · 1.9K citations · Full text

, , +13

Induction of Tumor Immunity by Removing CD25+CD4+ T Cells: A Common Basis Between Tumor Immunity and Autoimmunity

Jun Shimizu, Sayuri Yamazaki, Shimon Sakaguchi · The Journal of Immunology · 1999 · 1.5K citations · Full text

, , +17